Viral load and CD4% are often not available in resource-limited settings for monitoring children's responses to antiretroviral treatment (ART). We aimed to construct normative curves for weight gain at six-, twelve-, eighteen-, and twenty-four-month post initiation of ART in children, and to assess the association between poor weight gain and subsequent responses to ART
Background: Deficits in growth observed in HIV-infected children in resource-poor settings can be re...
International audienceBackground: Antiretroviral treatment (ART) has been shown to have a beneficial...
International audienceBackground: Antiretroviral treatment (ART) has been shown to have a beneficial...
Viral load and CD4% are often not available in resource-limited settings for monitoring children's r...
BACKGROUND Viral load and CD4% are often not available in resource-limited settings for monitorin...
Construct percentile curves for 6-month gain in weight, height, CD4 cell count, and CD4 percentage (...
Construct percentile curves for 6-month gain in weight, height, CD4 cell count, and CD4 percentage (...
Objective: To identify baseline demographic and clinical risk factors associated with poor CD4 and w...
BACKGROUND: Poor growth is an indication for antiretroviral therapy (ART) and a criterion for treatm...
Objective Pediatric antiretroviral therapy (ART) for children with HIV (CHIV) must be dosed appropr...
Background: Deficits in growth observed in HIV-infected children in resource-poor settings can be re...
Backgroung: Antiretroviral therapy (ART) has revolutionized the treatment of HIV, but substantial dr...
Background: Deficits in growth observed in HIV-infected children in resource-poor settings can be re...
Backgroung: Antiretroviral therapy (ART) has revolutionized the treatment of HIV, but substantial dr...
Backgroung: Antiretroviral therapy (ART) has revolutionized the treatment of HIV, but substantial dr...
Background: Deficits in growth observed in HIV-infected children in resource-poor settings can be re...
International audienceBackground: Antiretroviral treatment (ART) has been shown to have a beneficial...
International audienceBackground: Antiretroviral treatment (ART) has been shown to have a beneficial...
Viral load and CD4% are often not available in resource-limited settings for monitoring children's r...
BACKGROUND Viral load and CD4% are often not available in resource-limited settings for monitorin...
Construct percentile curves for 6-month gain in weight, height, CD4 cell count, and CD4 percentage (...
Construct percentile curves for 6-month gain in weight, height, CD4 cell count, and CD4 percentage (...
Objective: To identify baseline demographic and clinical risk factors associated with poor CD4 and w...
BACKGROUND: Poor growth is an indication for antiretroviral therapy (ART) and a criterion for treatm...
Objective Pediatric antiretroviral therapy (ART) for children with HIV (CHIV) must be dosed appropr...
Background: Deficits in growth observed in HIV-infected children in resource-poor settings can be re...
Backgroung: Antiretroviral therapy (ART) has revolutionized the treatment of HIV, but substantial dr...
Background: Deficits in growth observed in HIV-infected children in resource-poor settings can be re...
Backgroung: Antiretroviral therapy (ART) has revolutionized the treatment of HIV, but substantial dr...
Backgroung: Antiretroviral therapy (ART) has revolutionized the treatment of HIV, but substantial dr...
Background: Deficits in growth observed in HIV-infected children in resource-poor settings can be re...
International audienceBackground: Antiretroviral treatment (ART) has been shown to have a beneficial...
International audienceBackground: Antiretroviral treatment (ART) has been shown to have a beneficial...